Barely Significant

Excerpts

3,685 sentences · 1 filter applied

In a large population-based cohort study of postmenopausal women with a history of oral bisphosphonate exposure, the use of Dmab was associated with a modestly significant 13% decreased risk of subsequent breast cancer, suggesting a potential protective effect of Dmab use on breast cancer risk in older women previously treated with bisphosphonates [ 34 ].
Following addition of a TF blocking antibody, the lag phase did not change in pancreatic cancer patients and healthy controls, Vmax decreased significantly in pancreatic cancer patients but not in controls, ΔAbs decreased significantly in pancreatic cancer patients and in healthy controls, and time to peak fibrin generation was reduced in pancreatic cancer patients with borderline significance, but not in controls ( Figure 2 ). 3.4.